KROMASURE™ InSite ensures Edit Site Integrity throughout the entire cell and gene therapy workflow by providing precise characterization of genomic edits. Whether analyzing a single locus or multiple edit sites.
InSite detects ~2KB transgene insertions and provides a comprehensive view of copy number, transgene orientation, and off-target effects, complementing sequencing data for a robust genome integrity assessment.
For Starting Material Analysis including strucural characterization of the genome and comparitive reporting of cells during multiple passages to measure genomic stability over time.
Throughout the entire cell and gene therapy process, from R&D to the clinic, characterization of the genome is a critical component of ensuring the edit integrity of each gene editing platform. Whether the process involves a single locus or multiple edit sites, KROMASURE InSite can detect small structural variants and transgene inserts, providing confidence for edit integrity.
Utilizing proprietary Advanced Fluorescent Hybridization technology (dGH) KROMASURE Insite provides direct visualization of:
KROMASURE™ InSite offers access to our proprietary solution dGH that gives critical insights into edit site integrity and transgene mapping.